SCHEMBL19987707

SCHEMBL19987707

CN1CCN(CCOc2cc3nccc(Oc4ccc(N(C(=O)C5(C(N)=O)CC5)c5ccc(F)cc5)cc4F)c3cn2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 18/20 0.43
AXL P30530 5/20 0.43
KDR P35968 3/20 0.43
EGFR P00533 3/20 0.43
PLK4 O00444 2/20 0.43
AURKA O14965 2/20 0.43
RIPK2 O43353 2/20 0.43
STK10 O94804 2/20 0.43
MAP4K4 O95819 2/20 0.43
FYN P06241 2/20 0.43
YES1 P07947 2/20 0.43
LYN P07948 2/20 0.43
SRC P12931 2/20 0.43
FER P16591 2/20 0.43
MAP2K2 P36507 2/20 0.43
CSK P41240 2/20 0.43
ABL2 P42684 2/20 0.43
LIMK1 P53667 2/20 0.43
PTK2 Q05397 2/20 0.43
STK4 Q13043 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19987810 0.92 MET (0.49) METAXLKDREGFRPLK4
SCHEMBL19987753 0.88 MET (0.41) METAXLKDREGFRPLK4
SCHEMBL19987725 0.88 MET (0.46) METAXLKDREGFRPLK4
SCHEMBL19987715 0.87 MET (0.36) METAXLKDREGFRPLK4
SCHEMBL19987745 0.86 AXL (0.49) METAXLKDREGFRPLK4
SCHEMBL19987757 0.86 MET (0.49) METAXLKDREGFRPLK4
SCHEMBL19987747 0.86 AXL (0.40) METAXLKDREGFRPLK4
SCHEMBL19987761 0.86 MET (0.38) METAXLKDREGFRPLK4
SCHEMBL19987709 0.85 MET (0.41) METAXLKDREGFRPLK4
SCHEMBL371886 0.85 MET (0.61) METAXLKDREGFRPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-07-14 US claimed
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2018-08-30 US claimed
EP-3299369-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2018-03-28 EP claimed
EP-3299369-B1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2020-11-11 EP disclosed
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-07-14 US disclosed
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2018-08-30 US disclosed
EP-3299369-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2018-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180244667-A1 PYRIDO-AZAHETERECYDIC COMPOUND AND PREPARATION METHOD AND USE THEREOF MET, MERTK, DMPK MET 1/4885AXL 212/4885KDR 210/4885
US-10710996-B2 Pyrido-azaheterecydic compound and preparation method and use thereof MET, MERTK, DMPK MET 1/4885AXL 212/4885KDR 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.